SCHEMBL24671110

SCHEMBL24671110

CCc1ccc(NC(=O)C(C)C)cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.57
ALDH1A1 P00352 8/20 0.48
RAB9A P51151 6/20 0.48
NPC1 O15118 4/20 0.48
TP53 P04637 3/20 0.48
KDM4E B2RXH2 1/20 0.48
KMT2A Q03164 4/20 0.46
MEN1 O00255 2/20 0.46
MAPT P10636 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
CYP2C19 P33261 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
LMNA P02545 1/20 0.45
ALOX15 P16050 1/20 0.45
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10727400 0.85 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1RAB9ANPC1TP53
SCHEMBL25139669 0.82 L3MBTL1 (0.55) SMN1; SMN2ALDH1A1RAB9ANPC1TP53
SCHEMBL15061717 0.81 KMT2A (0.50) SMN1; SMN2ALDH1A1RAB9ANPC1TP53
SCHEMBL2619354 0.80 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1RAB9ANPC1TP53
SCHEMBL19110994 0.79 SMN1; SMN2 (0.49) SMN1; SMN2RAB9ANPC1TP53KDM4E
SCHEMBL16252551 0.78 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1RAB9ANPC1TP53
SCHEMBL22540339 0.77 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1RAB9ANPC1TP53
SCHEMBL9764596 0.77 ALDH1A1 (0.57) SMN1; SMN2ALDH1A1RAB9ANPC1TP53
SCHEMBL24670521 0.77 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1RAB9ANPC1TP53
SCHEMBL19699499 0.75 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1RAB9ANPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235715-A1 COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE NURIX THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed